← boothcheck

CL vs HLN stock comparison

COLGATE-PALMOLIVE COMPANY vs Haleon plc, two Household Products stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Colgate-Palmolive sells oral and home care worldwide, banking 10.04% of sales as profit and yielding 5.09% in free cash. Haleon runs consumer-health brands like Sensodyne and Advil, wider at 15.23% margin but lighter on cash return at 3.53%. The market pays up for both, 35.66 times earnings for Colgate and 39.25 for Haleon, so neither is a bargain on price. Colgate hands shareholders a 2.26% dividend and trades at $74.1B; Haleon is larger at $83.0B. Haleon carries no net debt (d/e 0) and posts a 10.19% return on equity against its 3.98 times book. Two toothpaste-adjacent staples, close in size, both richly valued.

Comparison updated 2026-07-11.

CL vs HLN: the numbers

MetricCLHLN
Price$92.27$9.77
Market cap$74.3B$87.8B
SectorHousehold ProductsHousehold Products
StageMatureMature
Implied growth (priced in)+0.1%+16.2%
P/E35.841.5
P/B152.854.21
P/S3.576.29
EV/EBITDA21.124.5
Revenue growth+4.3%+3.9%
Gross margin60.6%64.2%
Operating margin18.1%21.9%
Net margin10.0%15.2%
Return on equity429.6%10.2%
Return on assets12.6%5.2%
Return on invested capital28.9%11.4%
FCF yield5.1%3.3%
Dividend yield2.3%
Debt / equity16.330.00
Current ratio1.020.92
Altman Z (solvency)6.484.34
Piotroski F (quality)7 / 98 / 9
Full CL report → Full HLN report →
Get boothcheck's read on CL and HLN, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.